Cepheid has introduced the GeneXpert ® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology. The latest addition to Cepheid's GeneXpert ® family of real-time PCR devices ...
Mr Salako attributed the progress to strategic expansion of diagnostic networks, especially the GeneXpert network, which has increased from 32 machines in 2012 to 527 in 2026, and TB-TrueNAT capacity, ...
Renowned molecular diagnostics provider CepheidCPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...
On May 26, we issued an updated research report on Sunnyvale, CA-based molecular diagnostics company – Cepheid CPHD – which develops and markets fully integrated systems for clinical and non-clinical ...
Tuberculosis has high prevalence in India. 26% of the cases of tuberculosis are here in India. There are many people that are affected but most importantly 850,000 people go undetected, or undiagnosed ...
The Xpert MTB/XDR test developed by the Foundation for Innovative New Diagnostics (FIND) and Cepheid Inc. quickly indicates whether a patient has a dangerous – and rapidly increasing – strain of ...